116 related articles for article (PubMed ID: 31773992)
1. Employer-perspective cost comparison of surgical treatments for abnormal uterine bleeding.
Miller JD; Bonafede MM; Pohlman SK; Cholkeri-Singh A; Troeger KA
J Comp Eff Res; 2020 Jan; 9(1):67-77. PubMed ID: 31773992
[No Abstract] [Full Text] [Related]
2. Economic Evaluation of Global Endometrial Ablation Versus Inpatient and Outpatient Hysterectomy for Treatment of Abnormal Uterine Bleeding: US Commercial and Medicaid Payer Perspectives.
Miller JD; Bonafede MM; Cai Q; Pohlman SK; Troeger KA; Cholkeri-Singh A
Popul Health Manag; 2018 Mar; 21(S1):S1-S12. PubMed ID: 29570003
[TBL] [Abstract][Full Text] [Related]
3. Comparison of direct and indirect costs of abnormal uterine bleeding treatment with global endometrial ablation and hysterectomy.
Bonafede MM; Miller JD; Lukes A; Meyer NM; Lenhart GM
J Comp Eff Res; 2015 Mar; 4(2):115-22. PubMed ID: 25496448
[TBL] [Abstract][Full Text] [Related]
4. Cost-Effectiveness of Global Endometrial Ablation vs. Hysterectomy for Treatment of Abnormal Uterine Bleeding: US Commercial and Medicaid Payer Perspectives.
Miller JD; Lenhart GM; Bonafede MM; Lukes AS; Laughlin-Tommaso SK
Popul Health Manag; 2015 Oct; 18(5):373-82. PubMed ID: 25714906
[TBL] [Abstract][Full Text] [Related]
5. Cost effectiveness of endometrial ablation with the NovaSure(®) system versus other global ablation modalities and hysterectomy for treatment of abnormal uterine bleeding: US commercial and Medicaid payer perspectives.
Miller JD; Lenhart GM; Bonafede MM; Basinski CM; Lukes AS; Troeger KA
Int J Womens Health; 2015; 7():59-73. PubMed ID: 25610002
[TBL] [Abstract][Full Text] [Related]
6. Cost burden and treatment patterns associated with management of heavy menstrual bleeding.
Jensen JT; Lefebvre P; Laliberté F; Sarda SP; Law A; Pocoski J; Duh MS
J Womens Health (Larchmt); 2012 May; 21(5):539-47. PubMed ID: 22360696
[TBL] [Abstract][Full Text] [Related]
7. Cost and quality-of-life issues associated with different surgical therapies for the treatment of abnormal uterine bleeding.
Hidlebaugh DA
Obstet Gynecol Clin North Am; 2000 Jun; 27(2):451-65. PubMed ID: 10991717
[TBL] [Abstract][Full Text] [Related]
8. Endometrial ablation in the management of abnormal uterine bleeding.
Laberge P; Leyland N; Murji A; Fortin C; Martyn P; Vilos G; ; Leyland N; Wolfman W; Allaire C; Awadalla A; Dunn S; Heywood M; Lemyre M; Marcoux V; Potestio F; Rittenberg D; Singh S; Yeung G;
J Obstet Gynaecol Can; 2015 Apr; 37(4):362-79. PubMed ID: 26001691
[TBL] [Abstract][Full Text] [Related]
9. A randomised controlled trial of Outpatient versus inpatient Polyp Treatment (OPT) for abnormal uterine bleeding.
Clark TJ; Middleton LJ; Cooper NA; Diwakar L; Denny E; Smith P; Gennard L; Stobert L; Roberts TE; Cheed V; Bingham T; Jowett S; Brettell E; Connor M; Jones SE; Daniels JP
Health Technol Assess; 2015 Jul; 19(61):1-194. PubMed ID: 26240949
[TBL] [Abstract][Full Text] [Related]
10. What are the total costs of surgical treatment for uterine fibroids?
Carls GS; Lee DW; Ozminkowski RJ; Wang S; Gibson TB; Stewart E
J Womens Health (Larchmt); 2008 Sep; 17(7):1119-32. PubMed ID: 18687032
[TBL] [Abstract][Full Text] [Related]
11. Payer cost savings with endometrial ablation therapy.
London R; Holzman M; Rubin D; Moffitt B
Am J Manag Care; 1999 Jul; 5(7):889-97. PubMed ID: 10557409
[TBL] [Abstract][Full Text] [Related]
12. Relative costs of gynecologic endoscopy vs traditional surgery for treatment of abnormal uterine bleeding.
Hidlebaugh DA
Am J Manag Care; 2001 Sep; 7 Spec No():SP31-7. PubMed ID: 11599673
[TBL] [Abstract][Full Text] [Related]
13. Uterine fibroid treatment patterns in a population of insured women.
Lee DW; Gibson TB; Carls GS; Ozminkowski RJ; Wang S; Stewart EA
Fertil Steril; 2009 Feb; 91(2):566-74. PubMed ID: 18304543
[TBL] [Abstract][Full Text] [Related]
14. An economic evaluation of outpatient versus inpatient polyp treatment for abnormal uterine bleeding.
Diwakar L; Roberts TE; Cooper NA; Middleton L; Jowett S; Daniels J; Smith P; Clark TJ;
BJOG; 2016 Mar; 123(4):625-31. PubMed ID: 26011792
[TBL] [Abstract][Full Text] [Related]
15. Retrospective database analysis of clinical outcomes and costs for treatment of abnormal uterine bleeding among women enrolled in US Medicaid programs.
Bonafede MM; Miller JD; Laughlin-Tommaso SK; Lukes AS; Meyer NM; Lenhart GM
Clinicoecon Outcomes Res; 2014; 6():423-9. PubMed ID: 25336979
[TBL] [Abstract][Full Text] [Related]
16. Hysteroscopy versus hysterectomy for the treatment of abnormal uterine bleeding: a comparison of cost.
Brumsted JR; Blackman JA; Badger GJ; Riddick DH
Fertil Steril; 1996 Feb; 65(2):310-6. PubMed ID: 8566254
[TBL] [Abstract][Full Text] [Related]
17. A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcome at four years. Aberdeen Endometrial Ablation Trials Group.
Br J Obstet Gynaecol; 1999 Apr; 106(4):360-6. PubMed ID: 10426244
[TBL] [Abstract][Full Text] [Related]
18. [Analysis from the French DRG-based information system (PMSI) of conservative surgical treatment for abnormal uterine bleeding in 2008-2010].
Fernandez H; Villefranque V; Panel P
J Gynecol Obstet Biol Reprod (Paris); 2015 May; 44(5):411-8. PubMed ID: 25721347
[TBL] [Abstract][Full Text] [Related]
19. Women with Newly Diagnosed Uterine Fibroids: Treatment Patterns and Cost Comparison for Select Treatment Options.
Bonafede MM; Pohlman SK; Miller JD; Thiel E; Troeger KA; Miller CE
Popul Health Manag; 2018 Mar; 21(S1):S13-S20. PubMed ID: 29649369
[TBL] [Abstract][Full Text] [Related]
20. Office endometrial ablation with local anesthesia using the HydroThermAblator system: Comparison of outcomes in patients with submucous myomas with those with normal cavities in 246 cases performed over 5(1/2) years.
Glasser MH; Heinlein PK; Hung YY
J Minim Invasive Gynecol; 2009; 16(6):700-7. PubMed ID: 19896596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
